| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT5B mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT5B mRNA" | 27188386 |
| C015001 | arsenite | arsenite results in increased methylation of MGAT5B promoter | 23974009 |
| C006780 | bisphenol A | bisphenol A results in increased expression of MGAT5B mRNA | 27685785 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of MGAT5B promoter | 27312807 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of MGAT5B mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of MGAT5B gene | 28505145 |
| C018475 | butyraldehyde | butyraldehyde results in decreased expression of MGAT5B mRNA | 26079696 |
| D003471 | Cuprizone | Cuprizone results in decreased expression of MGAT5B mRNA | 27523638 |
| D003471 | Cuprizone | Cuprizone results in increased expression of MGAT5B mRNA | 26577399 |
| D016572 | Cyclosporine | Cyclosporine results in decreased methylation of MGAT5B promoter | 27989131 |
| D003976 | Diazinon | Diazinon results in increased methylation of MGAT5B gene | 22964155 |
| D005038 | Ethylnitrosourea | Ethylnitrosourea results in increased mutagenesis of MGAT5B intron | 27776689 |
| D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MGAT5B mRNA | 26378955 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of MGAT5B mRNA" | 20188158 |
| D008777 | Methyltestosterone | Methyltestosterone results in decreased expression of MGAT5B mRNA | 29191790 |
| D016686 | Monocrotaline | Monocrotaline results in increased expression of MGAT5B mRNA | 28818515 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of MGAT5B protein | 24625837 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT5B mRNA" | 27188386 |
| D011441 | Propylthiouracil | Propylthiouracil results in increased expression of MGAT5B mRNA | 24780913 |
| D012715 | Sesame Oil | Sesame Oil results in increased expression of MGAT5B mRNA | 29191790 |
| D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MGAT5B mRNA | 26378955 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of MGAT5B mRNA | 21570461 |
| C012589 | trichostatin A | trichostatin A results in increased expression of MGAT5B mRNA | 24619417 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of MGAT5B mRNA" | 26179874 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of MGAT5B mRNA | 23179753 |